Sharing a post from Dr. Gary Gordon, emphasizing the importance of diagnosing and treating thyroid imbalances. At our office, we have found Thyroflex to be an excellent way to assess the functioning of the thyroid gland. We also test the blood for the active hormones and find that the results from our Thyroflex readings are more accurate and more valuable in terms of adequately treating thyroid imbalances. The result is that our patients feel more energy, are able to maintain their desired weight, and experience a stronger immune system and a more positive attitude.
Here’s to supporting your body’s ability to heal itself, and regaining energy, vitality and a greater sense of well-being.
There is an epidemic of patients who need thyroid support! The attached Pubmed report shows how thyroid can protect pregnancies from untoward outcomes.
Nonetheless, the current January 2011 Townsend Newsletter reports that the Oregon Medical Board is attacking a licensed MD there for prescribing thyroid, because the indicated T4 and TSH target levels were not present. They are ignoring all of the overwhelming clinical evidence that the patient needed, and benefited by, the thyroid prescription. As one nutritional therapist and patient of this doctor declares, the Oregon Medical Board should emulate the doctor – not pursue internal complaints.
This is very sad since subclinical hypothyroidism is EPIDEMIC in our toxic world. Just consider the levels of Fluoride and Bromide present today that induce iodine deficiency in our population, as one cause of suboptimal thyroid function. For many other causes please consider owning the new text on Nutritional Medicine by Dr. Alan Gaby with nearly 30,000 references behind it.
View the report below on levothyroxine and infertile women with hypothyroidism. How many miscarriages or other pregnancy problems would be eliminated if doctors were not living in fear of their medical licenses? Read Dr. Broda Barnes’ book on thyroid disease, ‘Hypothyroidism: The Unsuspected Illness’ (later reviewed by Dr. Stephen Langer), and then the book ‘Hypothyroidism Type 2: The Epidemic’ by Dr. Mark Starr. These will bring the rationale for diagnosing borderline or subclinical hypothyroidism into clear focus.
We should err on the side of more thyroid support for patients since there are so many contributors to low thyroid function, instead of putting doctors (and their patients) in harm’s way for practicing real medicine.
Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
Fertil Steril. 2010 Dec 28. [Epub ahead of print]
Effect of levothyroxine treatment on in vitro fertilization and pregnancy outcome in infertile women with subclinical hypothyroidism undergoing in vitro fertilization/intracytoplasmic sperm injection.
Kim CH, Ahn JW, Kang SP, Kim SH, Chae HD, Kang BM.
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, South Korea.
OBJECTIVE: To investigate whether levothyroxine (LT4) treatment has beneficial effects on IVF results and pregnancy outcome in infertile patients with subclinical hypothyroidism undergoing IVF/intracytoplasmic sperm injection (ICSI).
DESIGN: Prospective, randomized trial.
SETTING: University-affiliated infertility clinic.
PATIENT(S): A total of 64 infertile patients with subclinical hypothyroidism, defined as an elevated serum TSH level associated with a normal free T4 level and without frank symptoms of hypothyroidism.
INTERVENTION(S): Patients were randomized into an LT4 treatment group or control group. For the LT4 treatment group, 50 μg LT4 was administered from the first day of controlled ovarian stimulation for IVF/ICSI.
MAIN OUTCOME MEASURE(S): Results of IVF and pregnancy outcome.
RESULT(S): There were no differences in patient characteristics between the two groups. Total dose and days of recombinant human FSH used for controlled ovarian stimulation were also similar. The number of grade I or II embryos was significantly higher in the LT4 treatment group than in the control group. There was no significant difference in the clinical pregnancy rate per cycle between the two groups. However, the miscarriage rate was significantly lower in the LT4 treatment group than in the control group. Embryo implantation rate and live birth rate were significantly higher in the LT4 treatment group. In the control group, both thyroid peroxidase antibody and thyroglobulin antibody levels were significantly higher in the miscarried subgroup than in the delivered subgroup.
CONCLUSION(S): LT4 treatment can improve embryo quality and pregnancy outcome in subclinical hypothyroid women undergoing IVF/ICSI.
Copyright Â© 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
PMID: 21193190 [PubMed - as supplied by publisher]